CDMA Clinical Operations Study Management Intern

Roche

Nov 27, 2023

Applications are closed

Internship
Full-time
Off-cycle Internship
Science
San Francisco

Requirements

Required Education:
Just BS & MS: Undergraduates who have completed at least 3 years of undergraduate coursework at a university, or current graduate students pursuing a Masters or recent grads (BS or MS) within two years.
Preferred Majors:
Biology, Medical Technology, Biochemistry, Microbiology/Immunology
Required skills:
Course work experience in Biological Sciences
Understanding the regulatory environment and requirements of the In-Vitro Diagnostics development process.
Completed at least 3 years of college/university to be eligible for the program.
Must have a ≥3.0 GPA
Minimum availability of 12 weeks (Required start on or before program Welcome Reception and end date on or after Summer End Poster Symposium).
Other Preferred Qualifications:
Excellent communication, collaboration, and interpersonal skills.
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion.

Responsibilities

The candidate will conduct clinical trials within Invitro Diagnostics. Training on RDS policies and procedures involved in, and related to, Clinical Operations both in pre-launch and post-launch studies. Creating and implementing training, process and tools to support the Clinical Operations Study Management team
Support activities related to eClinical Support Solutions tools such as CTMS and eTMF

Roche

Doing now what patients need next.

Science & Healthcare

Industry

10,001+

Employees

1896

Founded Year

Mission & Purpose

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).